1. 1) Ericsson, B.; Eriksson, P.O.; Lofroth, J.E.; Engstrom, S. Cubic phases as delivery systems for peptide drugs. ACS Symp. Ser. 469, 252-263 (1991).
2. 2) Kadhum, W.R.; Todo, H.; Sugibayashi, K. Skin permeation: Enhancing ability of liquid crystal formulations. in Percutaneous penetration enhancers chemical methods in penetration enhancement: Drug Manipulation Strategies and Vehicle Effects (Dragicevic-Curic, N.; Maibach, H. eds.). Springer-Verlag, Berlin, Heidelberg, pp. 243-253 (2015).
3. 3) Wallin, R.; Engstrom, S.; Mandenius, C.F. Stabilisation of glucose oxidase by entrapment in a cubic liquid crystalline phase. Biocatalysis 8, 73-80 (1993).
4. 4) Nylander, T.; Mattisson, C.; Razumas, V.; Miezes, Y.; Hakansson, B. A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase. Colloids Surf. A 114, 311-320 (1996).
5. 5) Caboi, F.; Nylander, T.; Razumas, V.; Talaikyte, Z.; Monduzzi, M.; Larsson, K. Structural effects, mobility, and redox behavior of vitamin K1 hosted in the monoolein:water liquid crystalline phases. Langmuir 13, 5476-5483 (1997).